CRDL - Cardiol Therapeutics - Stock Forecast

Coverage Performance Price Targets & Ratings Chart Insider Trading

CRDL is currently covered by 3 analysts with an average price target of $4.23. This is a potential upside of $2.43 (135%) from yesterday's end of day stock price of $1.8.

Cardiol Therapeutics's activity chart (see below) currently has 2 price targets and 8 ratings on display. The stock rating distribution of CRDL is 75% BUY and 25% HOLD.

Stock Analyst Price Targets - Review

Highest price target for CRDL is $3, Lowest price target is $3, average price target is $4.23.

Most recent stock forecast was given by CHARLES DUNCAN from CANTOR FITZGERALD on 14-Aug-2023.

Best performing analysts who are covering CRDL - Cardiol Therapeutics:

Edward Nash Charles Duncan Rahul Sarugaser

Currently out of the existing stock ratings of CRDL, 3 are a BUY (75%), 1 are a HOLD (25%).

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

3

$1.2 (66.67%)

8

7 months 14 days ago

0/2 (0%)

$2.07 (222.58%)

Buy

7

10 months 9 days ago

0/2 (0%)

$5.22 (293.26%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is CRDL (Cardiol Therapeutics) average time for price targets to be met?

On average it took 0 days on average for the stock forecasts to be realized with a an average price target met ratio 0

Which analyst has the current highest performing score on CRDL (Cardiol Therapeutics) with a proven track record?

EDWARD NASH

Which analyst has the current lower performing score on CRDL (Cardiol Therapeutics) with a proven track record?

RAHUL SARUGASER

Which analyst has the most public recommendations on CRDL (Cardiol Therapeutics)?

Edward Nash works at CANACCORD and has 9 price targets and 6 ratings on CRDL

Which analyst is the currently most bullish on CRDL (Cardiol Therapeutics)?

Charles Duncan with highest potential upside - $1.2

Which analyst is the currently most reserved on CRDL (Cardiol Therapeutics)?

Edward Nash with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?